You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Dow
Harvard Business School
McKinsey
Johnson and Johnson

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Granules India Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GRANULES INDIA, and what generic and branded alternatives to GRANULES INDIA drugs are available?

GRANULES INDIA has fourteen approved drugs.



Summary for Granules India
US Patents:0
Tradenames:11
Ingredients:11
NDAs:14

Drugs and US Patents for Granules India

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Granules India NAPROXEN SODIUM naproxen sodium TABLET;ORAL 091353-001 Sep 20, 2011 OTC No No   Start Trial   Start Trial
Granules India Ltd METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 209313-002 Mar 16, 2018 AB RX No No   Start Trial   Start Trial
Granules India Ltd GABAPENTIN gabapentin CAPSULE;ORAL 075360-002 Apr 6, 2005 AB RX No No   Start Trial   Start Trial
Granules India Ltd METHOCARBAMOL methocarbamol TABLET;ORAL 209312-002 May 7, 2018 AA RX No No   Start Trial   Start Trial
Granules India Ltd IBUPROFEN ibuprofen TABLET;ORAL 202312-001 Oct 7, 2016 OTC No No   Start Trial   Start Trial
Granules India Ltd GUAIFENESIN guaifenesin TABLET, EXTENDED RELEASE;ORAL 213420-002 May 8, 2020 OTC No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Colorcon
Baxter
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.